Symbol | Exchange | Currency |
|---|
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Neutral | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Buy | Buy | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.30 | 7.30 | 7.25 | 0.00 | 0.00% | 5.16M | Lagos | |||
| 9.75 | 9.90 | 9.70 | +0.20 | +2.06% | 1.55M | Lagos | |||
| 39.75 | 39.90 | 39.80 | +0.90 | +2.31% | 3.60M | Lagos | |||
| 2.27 | 2.28 | 2.26 | 0.000 | 0.00% | 4.84M | Lagos | |||
| 28.75 | 28.60 | 28.40 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 29.90 | 29.90 | 29.80 | +0.10 | +0.34% | 3.34M | Lagos | |||
| 105.55 | 105.55 | 105.55 | +0.05 | +0.05% | 74.84K | Lagos | |||
| 165.00 | 165.00 | 165.00 | 0.00 | 0.00% | 401.07K | Lagos | |||
| 3.15 | 3.15 | 3.05 | -0.040 | -1.25% | 1.44M | Lagos | |||
| 1.12 | 1.12 | 1.12 | +0.03 | +2.75% | 136.95K | Lagos | |||
| 21.00 | 21.00 | 21.00 | +0.10 | +0.48% | 1.14M | Lagos | |||
| 145.00 | 145.00 | 145.00 | 0.00 | 0.00% | 13.22K | Lagos | |||
| 5.40 | 5.40 | 5.40 | 0.00 | 0.00% | 613.00K | Lagos | |||
| 1.61 | 1.61 | 1.54 | +0.020 | +1.26% | 9.90M | Lagos | |||
| 2.13 | 2.10 | 2.10 | +0.12 | +6.06% | 765.17K | Lagos |
Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567 and KAND145 which block the Fractalkine receptor CX3CR1 and thus specific parts of the immune system for treatment of hyperinflammation HDAC6 for the treatment of nerve inflammation and pain; and ROR inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.